| PERIOD ENDING | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | | Total Revenue | 3,827 | 3,632 | 2,898 | 2,714 | | Cost of Revenue | 2,272 | 1,862 | 1,828 | 1,963 | | | Gross Profit | 1,555 | 1,770 | 1,070 | 751 | | | Operating Expenses | | Research Development | 1,160 | 1,178 | 1,105 | 1,103 | | Selling General and Administrative | 1,309 | 1,078 | 1,293 | 1,261 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (914) | (486) | (1,328) | (1,613) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,794) | 1,667 | (458) | (1,912) | | Earnings Before Interest And Taxes | (3,708) | 1,181 | (1,786) | (3,525) | | Interest Expense | (706) | 2,926 | 719 | (938) | | Income Before Tax | (3,002) | (1,745) | (2,505) | (2,587) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,002) | (1,745) | (2,505) | (2,587) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,002) | (1,745) | (2,505) | (2,587) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,002) | ($1,745) | ($2,505) | ($2,587) |
|
0.49% Nasdaq 
Income Statement
